Guest Editors' Message: Original Research from the Department of Surgery.

Journal of Surgical OncologyVolume 99, Issue 3 p. 135-136 Guest Editorial The role of microRNA in tumorigenesis: Key players or innocent bystanders Raneen Abu Sini MSc, Raneen Abu Sini MSc Surgical Oncology Laboratory, Department of Surgery, Hadassah Hebrew University Medical Center, Mount Scopus, Jerusalem, IsraelSearch for more papers by this authorBarry Trink PhD, Barry Trink PhD Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorAviram Nissan MD, Corresponding Author Aviram Nissan MD [email protected] Surgical Oncology Laboratory, Department of Surgery, Hadassah Hebrew University Medical Center, Mount Scopus, Jerusalem, IsraelP.O.B. 24035, Jerusalem 91240, Israel. Fax: 972-2-584-4028.Search for more papers by this author Raneen Abu Sini MSc, Raneen Abu Sini MSc Surgical Oncology Laboratory, Department of Surgery, Hadassah Hebrew University Medical Center, Mount Scopus, Jerusalem, IsraelSearch for more papers by this authorBarry Trink PhD, Barry Trink PhD Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorAviram Nissan MD, Corresponding Author Aviram Nissan MD [email protected] Surgical Oncology Laboratory, Department of Surgery, Hadassah Hebrew University Medical Center, Mount Scopus, Jerusalem, IsraelP.O.B. 24035, Jerusalem 91240, Israel. Fax: 972-2-584-4028.Search for more papers by this author First published: 15 December 2008 https://doi.org/10.1002/jso.21213Citations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume99, Issue31 March 2009Pages 135-136 RelatedInformation

I wish to thank Dr. Maria Siemionow for serving as guest editor and for the exceptional group of knowledgeable authors that she has brought together to write on “Allograft Transplantation” for Seminars in Plastic Surgery. Dr. Siemionow is known nationally and internationally for her 20 years of experimental work on composite tissue allografts and tolerance-inducing strategies. She received her medical degree from Karol Marcinkowski University of Medical Sciences in Poznan, Poland, in 1974 and completed residency training at the Institute for Orthopaedics and Rehabilitation Medicine in Poznan, Poland, in 1977 and a Neurosurgery and Traumatology residency at Municipal Hospital in Piekary, Slaskie, Finland. Dr. Siemionow secured additional years of specialty training at University Hospital in Helsinki, Finland, in hand surgery and at the University of Louisville Hospital as a Christine M. Kleinert Fellow in Hand Surgery and Research Fellow in Hand and Microsurgery. Dr. Siemionow worked as research director of the Division of Plastic and Reconstructive Surgery at the University of Utah School of Medicine for 5 years before joining the Cleveland Clinic in Ohio in 1995 where she heads Cleveland Clinic's Section on Plastic Surgery Research and is on staff with Cleveland Clinic's Transplantation Center and Departments of Orthopaedic Surgery and Immunology. She is also professor of surgery at the Department of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

Dr. Jaime L. Bohl is an Assistant Professor of Surgery, Department of Surgery, Wake Forest School of Medicine and a Colon and Rectal Surgeon at Wake Forest Baptist Health in Winston-Salem, North Carolina. Jaime was born in Rockville, Connecticut. She grew up in the suburbs of Boston, Massachusetts. Dr. Bohl graduated from Duke University in Durham, North Carolina and attended medical school at the University of Virginia in Charlottesville, Virginia. She completed her general surgery residency at Vanderbilt University in Nashville, Tennessee and her colorectal surgery training at the Lahey Clinic in Burlington, Massachusetts. After this, she joined the Ochsner Clinic Foundation as a Staff Colon and Rectal Surgeon in the Department of Colon and Rectal Surgery in New Orleans, Louisiana. In 2011, she was recruited to her present position. Dr. Bohl is a rising star in the area of hereditary colorectal cancer. She conducts research in this area and actively participates in forums and committees on a national level to improve our knowledge and management of these challenging patients. In addition to managing many patients with hereditary colorectal cancer, Dr. Bohl maintains a busy clinical colorectal surgery practice in a university setting; she also teaches and interacts with medical students and residents daily. In addition to her research efforts, Dr. Bohl has published four book chapters and over four peer-reviewed articles. These include several contributions to Clinics. Dr. Bohl is a fellow of the American College of Surgeons. She serves on several committees and is a member of multiple specialty societies. She is Board Certified in General Surgery and Colon and Rectal Surgery and is also listed in Best Doctors in America. Jaime lives in Winston-Salem with her husband Nick. When not working, she enjoys running and participating in international medical missions. On behalf of the readers of Clinics in Colon and Rectal Surgery, the Editorial Board thanks Dr. Bohl for serving as Guest Editor and for providing an important issue on hereditary colon and rectal cancer.

From the *Department of Surgery, School of Medicine, University of California, Irvine Orange, CA; and †Department of Surgery and Jichi Medical Simulation Center, Jichi Medical University, Shimotsuke City, Tochigi Japan. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Reprints: Alan T. Lefor, MD, MPH, Department of Surgery, Center for Graduate Medical Education, Jichi Medical University, Yakushiji 3311-1 Shimotsuke City, Tochigi 329-0498, Japan. E-mail: [email protected].

This special issue of Progress in Community Health Partnerships (PCHP), “Maximizing Community Contributions, Benefits, and Outcomes in Clinical and Translational Research,” seeks to advance the field of community-based health research by providing information, tools, and understanding of the accomplishments, best practices, and challenges that community and academic partners have experienced in their engagement with National Institutes of Health-funded Clinical and Translational Science Awardees (CTSAs) and other research entities.* Much of the editorial work has been performed by guest editors: a collaboration of academics and community-based partners who strived to publish papers that amplify community perspectives in clinical and translational research, including those involving participatory approaches with a wide range of communities, participants, settings, and geographic locations. The resulting special issue includes papers that cover a wide range of multidisciplinary topics that reflect collaborations across many diverse communities, CTSAs, and community-engaged practice-based research networks. Authored and co-authored by community partners, the papers often reflect the perspectives, experiences, contributions, and value that community partnerships add to the research enterprise. This issue advances novel ideas, evaluates the implementation and development of community– academic partnerships, and highlights best practices. The focus is on lessons learned from community engagement in health research that will strengthen the research enterprise while building community and academic capacity to engage effectively for the improvement of public health in our communities. The papers in this issue highlight the important concept of community-based participatory research (CBPR), which has varied definitions. CBPR is, however, generally used to describe qualitative, quantitative, and mixed-methods research that is designed, planned, and conducted by and in collaboration with institution-based researchers and “community-based entities,” such as members of community-based organizations, public interest groups, and/or other associations. Investigations are on a topic or area of need identified by members of the community or by the researchers. 1–4 CBPR is also considered to be an approach to research that aims to use and develop knowledge, products, and outcomes that are mutually beneficial to researchers and community members. This issue features eleven papers in five categories: Community Perspective, Original Research, Theory and Methods, Workin-Progress & Lessons Learned, and Policy and Practice. In response to a national solicitation, 27 manuscripts were received. The guest editors sent the articles out for review to both community and academic reviewers. One guest editor was assigned to each manuscript and led a teleconference discussion of the manuscript with the rest of the guest editors and then worked with PCHP’s editor to give feedback to authors, almost always seeking to highlight the community’s perspective on the collaboration. Ultimately, nine manuscripts were rejected, seven were judged as less in concert with the goals of the special issue and were accepted with revision for a regular issue of PCHP, five were accepted for the special issue with minor revisions, and six were * The CTSA program of the National Institutes of Health provides infrastructure support to facilitate translational research, to promote the training and career development of translational researchers, and to develop innovative methods and technologies to strengthen translational research. Currently, 61 medical research institutions in 30 states and the District of Columbia participate in the program. Until recently, the program required that each CTSA explicitly include a community engagement component.

I want to thank Dr. Geoffrey Hallock for serving as guest editor and the exceptional group of knowledgeable and experienced authors that he has brought together to write on “Frontiers in Endoscopic Plastic Surgery” for Seminars in Plastic Surgery. Dr. Hallock is a board-certified plastic surgeon who is well-known nationally and internationally for his reconstructive work. He received his medical degree from Jefferson Medical College in Philadelphia and trained in general surgery at Dartmouth. Dr. Hallock completed his plastic surgery residency at the University of North Carolina and went on to complete a cosmetic surgery fellowship in Miami. Currently, he is assistant chief of the Division of Plastic Surgery for Allentown Affiliated Hospitals and clinical associate professor in the Department of Surgery at Temple University. Dr. Hallock is an active member of numerous plastic surgery societies and a prolific writer on many different plastic surgery topics, having authored more than 300 journal articles and 32 book chapters. We are honored to have him as our guest editor.

bariatric surgery Stephen W. Trenkner, Alexander R. Margulis, Alfons Pomp Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Weill Cornell Medical College, 525 East 68th Street, F-053, New York, NY 10065, USA Section of Laparoscopic and Bariatric Surgery, Department of Surgery, Weill Medical College of Cornell University, New York Presbyterian Hospital, 525 East 68th Street, New York, NY 190065, USA

From the Department of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, PA. The author has disclosed that he has no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Reprints: Charles J. Yeo, MD, FACS, Department of Surgery, Co-Director: Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, 1015 Walnut St, Curtis Bldg, Room 620, Philadelphia, PA 19107. E-mail: [email protected].

Andras Guttman This special issue entitled BIOSEPARATIONS is a continuation of the well-established Bioanalysis series published annually in ELECTROPHORESIS during the past decade, focusing on cutting edge developments in separations for the biomedical and biotechnology fields, covering the most important aspects and the latest achievements. This issue is composed of 17 contributions including 2 review and 15 original research articles all reflecting the increasingly multidisciplinary nature in this area including hyphenated techniques and microchip techniques besides electric field mediated and liquid chromatographic based methods. The great majority of the original research articles cover protein and glycan analysis including proteomic and glycomic profiling in the context of disease monitoring or clinical treatments. This volume starts with two review articles, one discussing the latest developments in microfluidic electrophoretic mobility shift assays for quantitative biochemical analysis, while the other one gives a good overview on stationary development for glycoprotein and glycopeptide enrichment. The three papers in the Hyphenated Techniques section are about label-free relative quantification, N-glycomic profiling and on-line immunoaffinity solid-phase extraction methods. The two contributions in the Microchip section discuss chip electrophoretic separations of toxins and metabolic organic acids. The largest section of this issue is about proteomics, comprising seven original research papers discussing such issues as high throughput multicapillary SDS-gel electrophoresis, the analytical aspects of quality by design (QbD), proteomic characterization of body fluids, variations and overexpression in cancer as well as interactions with affinity reagents and network development for proteomics analysis. The last part of this volume is about the newly emerging field of glycomics comprising three papers on glucose unit database generation, hydrophilic interaction electrokinetic chromatography and glycation analysis. In accordance with the interest of the Journal, the guest editor kept the emphasis on presenting outstanding examples of bioseparation technology developments. Contributions about new separation technologies, improvements of existing methods and intuitive, elegant applications provide a representative snapshot on the “state of the art” of all aspects of bioseparations today. In recognition of his significant contribution to the field, this special issue is dedicated to the 65th birthday of Ziad El Rassi, the Editor-in-Chief of this journal. As the guest editor of this Special Issue, I would like to thank all the authors for their high quality contributions and the reviewers for their time and effort to provide constructive critiques to ensure the excellence of this issue. The support and continued interest of Editor-in-Chief Professor Ziad El Rassi during the preparation of this Special Issue is greatly appreciated. I also thank the logistical assistance of Dr. Laszlo Hajba during the submission management and review process. The next issue of this series will appear in June/July timeframe of 2015. Those who are interested in contributing to this upcoming issue are invited to submit suitable manuscripts by November 1, 2014 via the ELECTROPHORESIS web submission site indicating the inclusion of the manuscript in the special issue on ‘‘Bioseparations’’. Andras Guttman Guest Editor

Editorial: Proceedings and Symposia in CORR ®: What They Are, and Why We Publish Them

Special issue on all‐electric and hybrid‐electric flight

Guest Editorial: Poverty, development, and PEPFAR: A US strategy for combating the global HIV/AIDS epidemic

Health Services Research (HSR) is pleased to announce a new feature called ''The Theme Series.''The journal will from to time issue a call for papers on a specific ''theme'' considered to be of particular significance to the field and importance for current health care policy.Manuscripts submitted for the Theme Issue will undergo the usual HSR peer review process

“Less is more.”—Ludwig Mies van der Rohe As a medical editor, one hates to quibble with the words of a great architect. Indeed, in many areas of our lives, such as political campaigns, less may well be more. However, after attending recent Annual Meetings of the American Society of Clinical Oncology (ASCO), it occurs to me that there was a wealth of opportunities to hear and see firsthand the astonishing amount of high-quality research taking place in our field. The sheer quantity of information was staggering. In addition, a greater proportion of the clinical research centered on discoveries at the molecular level, revealing both new possibilities for therapy and for a widening gap between the laboratory and the clinic. The experience reinforced my impression that this is truly an exciting time to be part of the oncology community, and a challenging time for medical journalism. How do practitioners and clinical researchers incorporate these new findings into our thinking? How can all of this knowledge make us better deliverers of cancer care to our patients? To counterbalance the quotation by van der Rohe and to carry on the theme, I quote one of the great problem-solving architects, R. Buckminster Fuller, who said, “You can never learn less, you can only learn more.” In this spirit, the Editors of the Journal of Clinical Oncology are preparing a Special Series comprising 12 additional issues of the Journal each year, beginning in January 2005. Six of these issues will be composed of review articles in disease-specific areas, and six will focus on molecular oncology. Feedback we receive through readership surveys and informally from colleagues suggests that readers are eager to expand their knowledge of molecular oncology to build a firmer understanding of this growing field, in anticipation of integrating it into practice. We understand that this is the direction in which oncology is moving and want us all to be prepared as practice-changing findings emerge. After much discussion and planning by ASCO leadership, the JCO Editors will launch six new issues each year focusing on molecular oncology. These will be smaller than the typical issues of JCO— up to about 120 pages each—just the right length to peruse in one sitting, but substantive in content. The series will include original research articles, as well as practical review articles and other supporting editorial material, intended to place the studies in perspective for the practicing clinician. Because this is an emerging field, glossaries will be provided and detailed illustrations will accompany each article. The Web site, www.jco.org, will also have special features to enhance understanding. The term “Special Series” is intended to convey the creation of a specific home to highlight JCO’s commitment to researchers in molecular oncology, but articles within these issues will be cited the same way as any other JCO article. S. Gail Eckhardt, MD, is working with me as the Editor of this series. Each issue will also have one or more Guest Editors, who are inviting papers on the topic at hand and, ultimately, helping to attract the best original research in the field. The Editors are pleased to announce the issues for next year (Table 1). While these are the major themes of the first issues, the ultimate goal is to make JCO the home for the best molecular oncology articles, for both original research and review articles. Dr Eckhardt and I would be pleased to hear from you about ideas for future issues, for inquiries concerning articles for the Special Series, as well as for continuing publication of molecular oncology articles in the regular issues of JCO. We believe that this new format for JCO will

Journal of Surgical OncologyVolume 107, Issue 6 p. 563-564 Guest Editorial Rise of mastectomy Pamela R. Portschy MD, Pamela R. Portschy MD Division of Surgical Oncology, Department of Surgery, University of Minnesota, Minneapolis, MNSearch for more papers by this authorTodd M. Tuttle MD, MS, Corresponding Author Todd M. Tuttle MD, MS [email protected] Division of Surgical Oncology, Department of Surgery, University of Minnesota, Minneapolis, MNDivision of Surgical Oncology, Department of Surgery, University of Minnesota, 420 Delaware St. SE, Minneapolis, Minnesota 55455. Fax: 612-624-6969.===Search for more papers by this author Pamela R. Portschy MD, Pamela R. Portschy MD Division of Surgical Oncology, Department of Surgery, University of Minnesota, Minneapolis, MNSearch for more papers by this authorTodd M. Tuttle MD, MS, Corresponding Author Todd M. Tuttle MD, MS [email protected] Division of Surgical Oncology, Department of Surgery, University of Minnesota, Minneapolis, MNDivision of Surgical Oncology, Department of Surgery, University of Minnesota, 420 Delaware St. SE, Minneapolis, Minnesota 55455. Fax: 612-624-6969.===Search for more papers by this author First published: 16 April 2013 https://doi.org/10.1002/jso.23340Citations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume107, Issue61 May 2013Pages 563-564 RelatedInformation